The US Endometrial Ablation Devices market is witnessing robust growth, driven by increasing prevalence of abnormal uterine bleeding and adoption of minimally invasive procedures. The market size was valued at USD 580 Million in 2025 and is projected to reach USD 930 Million by 2035, exhibiting a CAGR of 4.8% from 2024 to 2035.
The economic impact of tariffs on "US Endometrial Ablation Devices".
Market Growth Drivers
Increasing adoption of minimally invasive and outpatient procedures is a major driver. Patients and healthcare providers prefer less invasive approaches due to reduced recovery time and lower complication risk. Companies like Hologic, Inc. have focused on advanced devices such as NovaSure V5, offering improved safety and efficacy, thus enhancing adoption rates in hospital and ambulatory settings.
Rising prevalence of abnormal uterine bleeding among women, along with a growing aging female population, has escalated demand for endometrial ablation. Boston Scientific Corporation reported a significant uptick in endometrial ablation device sales in 2023, reflecting the impact of patient awareness initiatives and broader insurance coverage across the US.
Market Trends
Growing integration of radiofrequency and cryoablation technologies is transforming treatment outcomes. For instance, Medtronic introduced enhanced radiofrequency devices that enable more uniform tissue ablation and reduced procedural times, leading to higher throughput in outpatient clinics.
Increased investment in digital healthcare solutions, such as remote patient monitoring and telehealth, is influencing how endometrial ablation services are delivered. CooperSurgical has leveraged digital consultation platforms to streamline patient selection and preoperative assessment, catering to evolving patient and provider preferences.
Market Opportunities
Expansion into underserved regional and community hospitals presents a substantial growth opportunity. Companies like Minerva Surgical are collaborating with regional hospital networks to provide training and resources, enabling wider adoption of endometrial ablation devices in non-metropolitan markets.
Development of next-generation ablation devices incorporating real-time imaging and AI-assisted guidance offers manufacturers avenues for product differentiation and premium pricing.
US Endometrial Ablation Devices Market Revenue (USD Million), 2020-2035
The chart depicts consistent growth in the US Endometrial Ablation Devices market from USD 400 million in 2020 to an estimated USD 930 million by 2035. The period between 2024 and 2030 shows accelerated adoption, driven by favorable reimbursement and new product launches. Growth stabilizes somewhat post-2030, indicating maturation of the outpatient ablation segment. This data reflects a steady CAGR of 4.8% during the forecast period.
US Endometrial Ablation Devices Market by Regions Share (%), 2025
The pie chart for 2025 demonstrates regional market shares: the West leads with 28% due to high healthcare facility density, while the South follows at 26% with significant hospital expansion. The Midwest and Northeast account for 22% and 19%, respectively, highlighting steady device adoption in both urban and rural settings. The Central region holds a minor share at 5%, reflecting emerging market status. These proportions are driven by demographic trends and regional healthcare infrastructure.
Recent Developments in US Endometrial Ablation Devices Market (Last 6 Months)
In April 2024, CooperSurgical announced the launch of a next-generation endometrial ablation system featuring enhanced thermal control and real-time monitoring. The product, designed to improve patient safety and procedural outcomes, targets both hospital and ambulatory settings.
In March 2024, Boston Scientific released updated clinical data from a nationwide registry demonstrating the superior long-term efficacy and reduced reintervention rates associated with its NovaSure device portfolio. The findings support ongoing clinical adoption while reinforcing Boston Scientific’s position in the US market.
In February 2024, Minerva Surgical disclosed a strategic partnership with a network of community hospitals across Texas and California to provide specialized endometrial ablation device training for gynecologists. This initiative aims to increase the reach of minimally invasive solutions for abnormal uterine bleeding and accelerate overall market penetration in underserved areas.
Press Releases